Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
For 20 years, every mayoral administration has explored taking over or facilitating the sale of the post office directly east of Lucas Oil Stadium—with each attempt failing to gain traction.
The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.
Citizens Energy said Eagle Creek will be one of 10 water sources that will be part of the supply program, which will provide 25 million gallons of water per day to Lebanon and the LEAP District by 2031.
For that devotion, and for a lifetime spent quietly strengthening the city around him, IBJ has named Bland the 32nd recipient of the Michael A. Carroll Award.
It’s just the latest landmark for Indianapolis-based Lilly, which was catapulted into the top spot as the world’s largest health care company by market capitalization in 2023.
As GLP-1 drugs for weight loss and diabetes drugs such as Zepbound and Mounjaro generate billions in sales, researchers at Eli Lilly and Co. and other pharma companies are exploring their potential for other purposes.
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
Lilly’s shares have taken off in the wake of several significant deals and after it received fast-track regulatory review for highly anticipated weight-loss pill orforglipron.
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce costs for patients on government-funded insurance and those paying out of pocket.
The reduced SNAP benefits delay and delay in providing them—not to mention the 24,000 federal workers in Indiana who are going without paychecks—mean there will be families who need help.
Thursday’s announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters.
The deal is seen as one of the most significant in the administration’s current drug-pricing push, given the potential effect on public health and spending on health care.
Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on weight loss drugs, including Lilly medications.
